Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia:: A model of hepatic encephalopathy in cirrhosis

被引:137
作者
Jover, Rodrigo
Rodrigo, Regina
Felipo, Vicente
Insausti, Ricardo
Saez-Valero, Javier
Garcia-Ayllon, M. Salud
Suarez, Isabel
Candela, Asuncion
Compan, Antonio
Esteban, Angel
Cauli, Omar
Auso, Eva
Rodriguez, Erika
Gutierrez, Ana
Girona, Eva
Erceg, Slaven
Berbel, Pere
Perez-Mateo, Miguel
机构
[1] Gen Hosp Univ Alicante, Dept Gastroenterol, Alicante 03010, Spain
[2] Ctr Invest, Neurobiol Lab, Valencia, Spain
[3] Univ Castilla La Mancha, Dept Hlth Sci, Albacete, Spain
[4] Univ Castilla La Mancha, CRIB, Fac Med, Albacete, Spain
[5] Univ Miguel Hernandez, Inst Neurociencias, Consejo Super Invest Cientificas, Alicante, Spain
[6] Univ Alcala de Henares, Fac Biol, Cellular Biol & Genet Dept, Madrid, Spain
[7] Univ Miguel Hernandez, Dept Surg, Alicante, Spain
[8] Gen Hosp Univ Alicante, Dept Lab, E-03080 Alicante, Spain
[9] Hop Gen Elche, Dept Gastroenterol, Alicante, Spain
关键词
D O I
10.1002/hep.21180
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Studies of the pathogenesis of hepatic encephalopathy are hampered by the lack of a satisfactory animal model. We examined the neurological features of rats after bile duct ligation fed a hyperammonemic diet (BDL+HD). Six groups were studied. sham, sham pair-fed, hyperammonemic, bile duct ligation (BDL), BDL pair fed, and BDL+HD. The BDL+HD rats were made hyperammonemic via an ammonia-containing diet that began 2 weeks after operation. One week later, the animals were sacrificed. BDL+HD rats displayed an increased level of cerebral ammonia and neuroanatomical characteristics of hepatic encephalopathy (HE), including the presence of type II Alzheimer astrocytes. Both BDL and BDL+HD rats showed activation of the inflammatory system. BDL+HD rats showed an increased amount of brain glutamine, a decreased amount of brain myo-inositol, and a significant increase in the level of brain water. In coordination tests, BDL+HD rats showed severe impairment of motor activity and performance as opposed to BDL rats, whose results seemed only mildly affected. In conclusion, the BDL+HD rats displayed similar neuroanatomical and neurochemical characteristics to human HE in liver cirrhosis. Brain edema and inflammatory activation can be detected under these circumstances. Supplementary material for this article can be found on the HEPATOLOGY website (http://interscience.wiley.com/Jpage/0270-9139/suppmat/index.html).
引用
收藏
页码:1257 / 1266
页数:10
相关论文
共 47 条
[1]   REVERSIBILITY OF CHOLESTATIC CHANGES FOLLOWING EXPERIMENTAL COMMON BILE-DUCT OBSTRUCTION - FACT OR FANTASY [J].
ARONSON, DC ;
CHAMULEAU, RAFM ;
FREDERIKS, WM ;
GOOSZEN, HG ;
HEIJMANS, HSA ;
JAMES, J .
JOURNAL OF HEPATOLOGY, 1993, 18 (01) :85-95
[2]  
ARONSON DG, 1995, LIVER, V15, P242
[3]   A SIMPLE ANIMAL-MODEL OF HYPERAMMONEMIA [J].
AZORIN, I ;
MINANA, MD ;
FELIPO, V ;
GRISOLIA, S .
HEPATOLOGY, 1989, 10 (03) :311-314
[4]   Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis [J].
Balata, S ;
Damink, SWMO ;
Ferguson, K ;
Marshall, I ;
Hayes, PC ;
Deutz, NEP ;
Williams, R ;
Wardlaw, J ;
Jalan, R .
HEPATOLOGY, 2003, 37 (04) :931-939
[5]   Infection, inflammation and hepatic encephalopathy, synergism redefined [J].
Blei, AT .
JOURNAL OF HEPATOLOGY, 2004, 40 (02) :327-330
[6]   AMMONIA - KEY FACTOR IN THE PATHOGENESIS OF HEPATIC-ENCEPHALOPATHY [J].
BUTTERWORTH, RF ;
GIGUERE, JF ;
MICHAUD, J ;
LAVOIE, J ;
LAYRARGUES, GP .
NEUROCHEMICAL PATHOLOGY, 1987, 6 (1-2) :1-12
[7]  
BYRD DJ, 1993, EUR J CLIN CHEM CLIN, V31, P197
[8]   TYPE-II ALZHEIMER CHANGE EXPERIMENTALLY PRODUCED IN ASTROCYTES IN RAT [J].
CAVANAGH, JB ;
KYU, MH .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1971, 12 (01) :63-&
[9]   Animal models of hepatic encephalopathy [J].
Chamuleau, RAFM .
SEMINARS IN LIVER DISEASE, 1996, 16 (03) :265-270
[10]   Altered modulation of soluble guanylate cyclase by nitric oxide in patients with liver disease [J].
Corbalán, R ;
Montoliu, C ;
Miñana, MD ;
Del Olmo, JA ;
Serra, MA ;
Aparisi, L ;
Rodrigo, JM ;
Felipo, V .
METABOLIC BRAIN DISEASE, 2002, 17 (04) :295-301